Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|October 27, 2007
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivativesWilliams Porcal, Paola Hernández, Mariana Boiani, et al.
Molecules (Basel, Switzerland)|August 15, 2015
3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action StudiesMarcos Couto, Carina Sánchez, Belén Dávila, et al.
European Journal of Medicinal Chemistry|August 19, 2008
In vitro and in vivo antitrypanosomatid activity of 5-nitroindazolesLucia Boiani, Alejandra Gerpe, Vicente J Arán, et al.
Journal of Medicinal Chemistry|May 26, 2006
2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agentsMariana Boiani, Lucía Boiani, Ana Denicola, et al.
Organic & Biomolecular Chemistry|July 6, 2018
Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with 99mTcMaría Fernanda García, Fabio Gallazzi, Mara de Souza Junqueira, et al.
Veterinary Sciences|August 26, 2018
Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal ActivityLuiz Saramago, Helga Gomes, Elena Aguilera, et al.
Bioorganic & Medicinal Chemistry|February 18, 2006
Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studiesAlejandra Gerpe, Gabriela Aguirre, Lucía Boiani, et al.
European Journal of Medicinal Chemistry|October 5, 2010
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activityGuzmán Alvarez, Beatriz Aguirre-López, Javier Varela, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas DiseaseElena Aguilera, Carina Sánchez, María Eugenia Cruces, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 5, 2021
99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging AgentsXimena Camacho, Carolina Perroni, Camila L Machado, et al.
Pageof 21